Inventor · disambiguated record
Richard W. Heidebrecht
Also filed as: HEIDEBRECHT JR RICHARD · HEIDEBRECHT JR RICHARD W · HEIDEBRECHT JR RICHARD WAYNE · HEIDEBRECHT RICHARD
27 granted patents·19 pending applications·222 citations·filing 2006–2024
96Inventor score
Files withSIGILON THERAPEUTICS INC14SCIFLUOR LIFE SCIENCES INC9PRECERES INC5MERCK SHARP & DOHME3GRIMM JONATHAN2
Top patents by PatentIndex Score
46 records- 0196US9593114B2Fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-yl)-3-arylpropanoic acid derivativesSCIFLUOR LIFE SCIENCES INC·Filed 2016·Granted Mar 14, 2017·8 cites·20 claims
- 0296US9266884B2Fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-y1)-3-arylpropanoic acid derivativesSCIFLUOR LIFE SCIENCES INC·Filed 2014·Granted Feb 23, 2016·14 cites·20 claims
- 0396US8901144B2Fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-yl)-3-arylpropanoic acid derivativesSCIFLUOR LIFE SCIENCES LLC·Filed 2014·Granted Dec 2, 2014·19 cites·14 claims
- 0495US9802933B2Fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-yl)-3-arylpropanoic acid derivativesSCIFLUOR LIFE SCIENCES INC·Filed 2016·Granted Oct 31, 2017·7 cites·17 claims
- 0595US9717729B2Fluorinated integrin antagonistsSCIFLUOR LIFE SCIENCES INC·Filed 2016·Granted Aug 1, 2017·14 cites·19 claims
- 0694US10155758B2Fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-yl)-3-arylpropanoic acid derivativesSCIFLUOR LIFE SCIENCES INC·Filed 2017·Granted Dec 18, 2018·5 cites·17 claims
- 0794US9518053B2Fluorinated integrin antagonistsSCIFLUOR LIFE SCIENCES INC·Filed 2014·Granted Dec 13, 2016·16 cites·18 claims
- 0893US7981874B2Phosphorus derivatives as histone deacetylase inhibitorsMERCK SHARP & DOHME·Filed 2007·Granted Jul 19, 2011·21 cites·17 claims
- 0993US7544695B2Spirocyclic compoundsMERCK & CO INC·Filed 2006·Granted Jun 9, 2009·29 cites·14 claims
- 1092US11685737B2Fluorinated integrin antagonistsOCUTERRA THERAPEUTICS INC·Filed 2020·Granted Jun 27, 2023·2 cites·25 claims
- 1191US10106537B2Fluorinated integrin antagonistsSCIFLUOR LIFE SCIENCES INC·Filed 2017·Granted Oct 23, 2018·7 cites·19 claims
- 1290US8026260B2Histone deacetylase inhibitors with aryl-pyrazolyl-motifsMERCK SHARP & DOHME·Filed 2006·Granted Sep 27, 2011·9 cites·15 claims
- 1390US7834026B2Spirocyclic compoundsMERCK SHARP & DOHME·Filed 2006·Granted Nov 16, 2010·17 cites·6 claims
- 1487US12162994B2Biocompatible hydrogel capsules and process for preparing sameSIGILON THERAPEUTICS INC·Filed 2019·Granted Dec 10, 2024·2 cites·14 claims
- 1586US12497399B2Fluorinated integrin antagonistsOCUTERRA THERAPEUTICS INC·Filed 2023·Granted Dec 16, 2025·0 cites·5 claims
- 1686US8119685B2Disubstituted aniline compoundsHEIDEBRECHT RICHARD·Filed 2007·Granted Feb 21, 2012·18 cites·10 claims
- 1785US8461189B2Pyridyl derivatives as histone deacetylase inhibitorsHEIDEBRECHT JR RICHARD W·Filed 2008·Granted Jun 11, 2013·15 cites·19 claims
- 1883US2025206893A1Biocompatible hydrogel capsules and process for preparing sameSIGILON THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1980US11945786B2Compounds, devices, and uses thereofSIGILON THERAPEUTICS INC·Filed 2017·Granted Apr 2, 2024·2 cites·11 claims
- 2079US9096559B24-carboxybenzylamino derivatives as histone deacetylase inhibitorsHARRINGTON PAUL·Filed 2013·Granted Aug 4, 2015·5 cites·3 claims
- 2179US8158825B2Modified malonate derivativesGRIMM JONATHAN·Filed 2006·Granted Apr 17, 2012·9 cites·17 claims
- 2278US12161760B2Implantable particles and related methodsSIGILON THERAPEUTICS INC·Filed 2019·Granted Dec 10, 2024·2 cites·27 claims
- 2376US9363992B2Hydrazinyl lipidoids and uses thereofPRECERES INC·Filed 2015·Granted Jun 14, 2016·1 cites·26 claims
- 2475US2024238328A1Sulfated Glycosaminoglycan Biomaterials as Proteoglycan MimicsGLYCOLOGIX INC·Filed 2024·Application pending·0 cites
- 2573US2021246132A1Fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-yl)-3-arylpropanoic acid derivativesSCIFLUOR LIFE SCIENCES INC·Filed 2020·Application pending·0 cites
- 2672US2025235409A1Implantable particles and related methodsSIGILON THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2767US2019263810A1Fluorinated integrin antagonistsSCIFLUOR LIFE SCIENCES INC·Filed 2019·Application pending·0 cites
- 2865US11911411B2Sulfated glycosaminoglycan biomaterials as proteoglycan mimicsGLYCOLOGIX LLC·Filed 2021·Granted Feb 27, 2024·0 cites·15 claims
- 2965US9339029B2Hydrazinyl lipidoids and uses thereofPRECERES INC·Filed 2015·Granted May 17, 2016·0 cites·24 claims
- 3064US9409869B1Hydrazinyl lipidoids and uses thereofPRECERES INC·Filed 2016·Granted Aug 9, 2016·0 cites·30 claims
- 3163US2016311762A1Hydrazinyl lipidoids and uses thereofPRECERES INC·Filed 2016·Application pending·0 cites
- 3253US2023045277A1Compounds, polymers, devices, and uses thereofSIGILON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3352US2023003706A1Methods of evaluating small molecule-modified polymers in compositionsSIGILON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3451US2022349896A1Methods of evaluating polypeptide-modified polymers in compositionsSIGILON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3550US2009156825A1Fluorescent compounds that bind to histone deacetylaseHEIDEBRECHT JR RICHARD W·Filed 2008·Application pending·0 cites
- 3650US2023303502A1Heteroaryl and heterocyclyl compoundsSIGILON THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3747US2023123802A1Compositions, devices, and methods for factor vii therapySIGILON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3846US2021145889A1Methods, compositions, and implantable elements comprising stem cellsSIGILON THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3944US2022000789A1Implantable devices for cell therapy and related methodsSIGILON THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4044US2011130361A1Silicon derivatives as histone deacetylase inhibitorsGRIMM JONATHAN·Filed 2008·Application pending·0 cites
- 4143US2022267794A1Compositions, devices, and methods for treating fabry diseaseSIGILON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4240US8759579B2Cyclobutyl sulfones as notch sparing gamma secretase inhibitorsHEIDEBRECHT RICHARD W·Filed 2009·Granted Jun 24, 2014·0 cites·14 claims
- 4338US2009062297A1Hydroxyalkylarylamide DerivativesHEIDEBRECHT RICHARD W·Filed 2007·Application pending·0 cites
- 4437US2020263196A1Methods, compositions, and implantable elements comprising active cellsSIGILON THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4536US2017325457A1Formulations for the delivery of active agents to insects, plants, and plant pathogensPRECERES INC·Filed 2017·Application pending·0 cites
- 4630US8871796B2Diaryl ether derivatives as notch sparing gamma secretase inhibitorsBROWN WILLIAM COLBY·Filed 2010·Granted Oct 28, 2014·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Richard W. Heidebrecht files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →